are glp 1 compounds going away Compounded GLP-1s Away? Not Entirely The GLP-1 drug shortage is

N115 LCD Determination Not Met Most common cause: Hemoglobin value missing from the progress note, so the payer cannot confirm the LCD threshold

Discussion The global diabetes epidemic, affecting approximately 828 million adults in 2022 32 , has driven widespread adoption of GLP-1 RAs due to their dual glycemic and weight management benefits 33,34,35

Label status: In January 2025, the Ozempic label was updated to state that it is not recommended in patients with severe gastroparesis, but does not indicate that the drug itself may cause the condition

Roger Harris concluded that CarnoSyn beta-alanine is the best way to increase carnosine levels in the body, leading to various health benefits

Wall Street analysts say a loosening of FDA restrictions could open a multibillion-dollar market for telehealth companies and compounders, Reuters reported